| Financial Year |
March 31 2023 |
| Monetary Funds |
1,084,929,579.57 |
| Held-for-trading Financial Assets |
3,871,173.84 |
| Notes Receivable |
554,602,399.06 |
| Accounts Receivable |
743,548,153.82 |
| Advances to Suppliers |
590,068,449.12 |
| Other Receivables |
64,201,457.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
541,143,815.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,881,547.34 |
| Total Current Assets |
4,049,510,421.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
953,347.22 |
| Long-term Equity Investment |
54,931,725.57 |
| Investment Properties |
176,957,764.84 |
| Fixed Assetes |
3,237,166,934.74 |
| Under-construction Projects |
107,198,489.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
567,412,226.39 |
| R&D expenses |
29,086,124.87 |
| Goodwill |
20,981,109.50 |
| Long-Term Deferred and Prepaid Expenses |
7,614,982.13 |
| Deferred Income Tax Assets |
132,350,166.08 |
| Other Non-Current Assets |
14,615,920.76 |
| Sub-Total of Non-Current Assets |
4,387,730,013.18 |
| Total Assets |
8,437,240,435.16 |
| Short-Term Loans |
755,313,202.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
111,684,736.94 |
| Accounts Payable |
537,405,290.12 |
| Accounts Received In Advance |
4,626,765.99 |
| Employee Compensation Payable |
25,639,120.74 |
| Taxes Payable |
80,336,891.52 |
| Interest Payable |
2,480,990.65 |
| Dividend Payable |
23,638,308.08 |
| Other payables |
1,093,051,935.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,818,036.79 |
| Other Current Liabilities |
347,327,915.95 |
| Sub-Total of Current Liabilities |
3,109,300,156.99 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
19,090,422.75 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
63,095,378.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
510,201,648.86 |
| Total Liabilities |
3,619,501,805.85 |
| Paid-In Capital(Or Share Stock) |
966,567,854.00 |
| Capital Surplus |
1,188,897,158.16 |
| Surplus Reserve |
78,560,133.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,253,337,488.41 |
| Minority Stockholder's Interest |
1,288,298,293.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,529,440,336.00 |
| Owner's Equity（Stockholder's Equity） |
4,817,738,629.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,437,240,435.16 |
